Drug intelligence / Profile preview

Daichi No Kampo Benpiyaku

Development stage
Unknown
Lead developer
Alinamin Pharmaceutical
Administration
Oral
01

Overview

Daichi No Kampo Benpiyaku is an over-the-counter (OTC) Kampo (traditional Japanese herbal) medicine developed and marketed by Alinamin Pharmaceutical for the relief of constipation and its associated symptoms, such as abdominal bloating, acne, and loss of appetite. The formulation is based on the traditional Kampo recipe Daio-Kanzo-To (Daiokanzoto), which consists of a combination of two key botanical ingredients: rhubarb (specifically "Shinshu Rhubarb") and licorice (specifically "Miyako Licorice"). The active components, particularly sennosides from rhubarb, are metabolized by intestinal bacteria into rheinanthrone, which stimulates peristalsis in the large intestine to promote smooth bowel movements. Licorice provides anti-inflammatory and antispasmodic effects to mitigate abdominal discomfort. It is typically administered orally before bedtime to produce gentle, natural-feeling bowel movements the following morning.

Brand names
Daichi No Kampo Benpiyaku
Other names
Daichi no Kampo LaxativeDaichi no Kanpo BenpiyakuDaichi no Kanpo Constipation MedicineDaio-Kanzo-ToDaiokanzoto大地の漢方便秘薬

Beyond the preview

Go deeper on Daichi No Kampo Benpiyaku.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daichi No Kampo Benpiyaku.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call